Adenosine instead of supranormal potassium in cardioplegic solution preserves endothelium-derived hyperpolarization

Oyvind Jakobsen1, Thor A Stenberg, Ole Losvik

  • 1Department of Cardiothoracic and Vascular Surgery, University Hospital of North Norway and Institute of Clinical Medicine, University of Tromsø, Norway. oyvind.jakobsen@fagmed.uit.no

Insights

Adenosine cardioplegia improves blood flow and preserves endothelial function after cardiac arrest. This method maintains endothelium-derived hyperpolarization-dependent vasodilation, unlike traditional hyperkalemic solutions.

Area of Science:

  • Cardiovascular Science
  • Surgical Research
  • Pharmacology

Background:

  • Cold crystalloid cardioplegia is standard for cardiac arrest.
  • Hyperkalemia in cardioplegia may impair vascular endothelial function.
  • Adenosine shows promise in improving cardioprotection.

Purpose of the Study:

  • To investigate if adenosine cardioplegia preserves postcardioplegic endothelial function.
  • To compare adenosine cardioplegia with hyperkalemic cardioplegia regarding endothelial function.
  • To assess the impact on nitric oxide, cyclooxygenase, and EDHF pathways.

Main Methods:

  • Pigs received either hyperkalemic or adenosine cardioplegia.
  • Coronary blood flow was monitored post-ischemia.
  • Isolated coronary artery rings were used to assess bradykinin-mediated relaxation with pathway inhibitors.

Main Results:

  • Adenosine group showed a trend towards increased coronary blood flow post-arrest.
  • In vitro, adenosine preserved endothelium-derived hyperpolarization (EDHF)-dependent vasodilation significantly more than hyperkalemic cardioplegia.
  • Hyperkalemic cardioplegia impaired EDHF-mediated relaxation.

Conclusions:

  • Adenosine cardioplegia enhances myocardial blood flow post-cardiac arrest.
  • Adenosine preserves EDHF-dependent vasodilation, crucial for endothelial health.
  • Adenosine is a superior alternative to hyperkalemia in cardioplegia for preserving vascular function.
Abstract

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...